AG
RMD icon

Algert Global’s ResMed RMD Stock Holding History

Algert Global’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,505
Closed -$518K – 1245
2023
Q3 		$518K Sell
3,505
-2,794
-44% -$505K 0.02% 736
2023
Q2 		$1.38M Buy
6,299
+52
+0.8% +$11.6K 0.06% 536
2023
Q1 		$1.37M Buy
+6,247
New +$1.36M 0.06% 503
2022
Q4 		– Sell
-3,054
Closed -$667K – 1256
2022
Q3 		$667K Sell
3,054
-1,368
-31% -$311K 0.04% 714
2022
Q2 		$927K Buy
+4,422
New +$941K 0.07% 511

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Algert Global's RMD Position: Q4 2023 in Review

Algert Global sold out of ResMed (RMD) in Q4 2023, closing a stake of 3,505 shares — an estimated $518K sold.

Algert Global first reported a position in RMD in Q2 2022 and held it in 5 quarters. The position peaked at $1.38M in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Algert Global reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 3,505 ResMed shares in Q4 2023, an estimated $518K.
  • Algert Global first reported a position in ResMed in Q2 2022 and held it in 5 quarters.
  • Algert Global's ResMed position peaked at $1.38M in Q2 2023.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.